MedTrace Logo

Multicenter Study on Cardiovascular and Metabolic Complications in Patients With Biochemically Silent Pheochromocytomas and Paragangliomas

NCT07316075 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2026-01-05

No results posted yet for this study

Summary

The aim of the study is to characterise the cardiovascular and metabolic complications pre- and post-surgery of patients with biochemically negative PPGL and to compare them with normal individuals and patients with secreting PPGLs age and sex matched.

Conditions

  • Cardiovascular Abnormalities
  • Arterial Blood Pressure
  • Heart Rate
  • Congestive Heart Failure Chronic
  • Coronary Syndrome
  • Cerebrovascular Disease
  • Myocarditis, Pericarditis
  • Hyperlipidaemia
  • Diabete Mellitus

Sponsors & Collaborators

  • Laikο General Hospital, Athens

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-02-05
Primary Completion
2024-12-01
Completion
2027-02-25

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07316075 on ClinicalTrials.gov